Recent Updates
Recently added Catalysts
ATHE Neutral Sentiment Score: 50/100

Market Announcement 28 January 2025 Alterity Therapeutics Limited (ASX: ATH) - Trading Halt Description The securities of Alterity Therapeutics Limited ( ATH') will be placed in trading halt at the request of ATH, pendin

Key Takeaway: Alterity Therapeutics Limited has requested a trading halt of its securities on the ASX as of January 28, 2025. This trading halt is set to last until the earlier of normal trading recommencing on January 30, 2025, or the release of a subsequent announcement. The trading halt is requested in compliance with ASX Listing Rule 17.1, and further details are pending.

Market Sentiment Analysis

Full Press Release Details

Alterity Therapeutics Limited
(ASX: ATH) - Trading Halt
The securities of Alterity Therapeutics Limited ( ATH')
will be placed in trading halt at the request of ATH, pending it releasing an announcement. Unless ASX decides otherwise, the securities
will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 30 January 2025 or when the announcement
is released to the market.
28 January 2025 Market Announcement 1/1
ASX Limited ASX Customer Service Centre 131 279 | asx.com.au
Adviser, Listings Compliance (Melbourne) ASX Limited
Request for a trading halt
Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE)
(the Company), requests that the Company's securities be placed into a trading halt with immediate effect.
For the purposes of Listing Rule 17.1, the Company provides
the following information:
Please contact us should you have any questions.
For and on behalf of the Board of Alterity Therapeutics Limited
Alterity Therapeutics Limited
Level 3, 460 Bourke Street, Melbourne,
T: +61 (0)3 9349 4906 | WWW.alteritytherapeutics.com

Frequently Asked Questions

What triggered the trading halt for Alterity Therapeutics?

The trading halt for Alterity Therapeutics was requested by the company pending an announcement.

How long will the trading halt last?

The trading halt will remain until normal trading resumes on 30 January 2025 or the announcement is made.

What is the ASX code for Alterity Therapeutics?

The ASX code for Alterity Therapeutics is ATH.

What information was provided to ASX regarding the halt?

Alterity Therapeutics provided information as required by Listing Rule 17.1 for the halt request.

How can I contact Alterity Therapeutics for inquiries?

You can contact Alterity Therapeutics at +61 (0)3 9349 4906 or via their website.

Last updated: Jan 28, 2025